2019
DOI: 10.1186/s12936-019-3004-7
|View full text |Cite
|
Sign up to set email alerts
|

Determinants of uptake of intermittent preventive treatment during pregnancy: a review

Abstract: Malaria in pregnancy (MiP) contributes to devastating maternal and neonatal outcomes. Coverage of intermittent preventive treatment during pregnancy (IPTp) remains alarmingly low. Data was compiled from MiP programme reviews and performed a literature search on access to and determinants of IPTp. National malaria control and reproductive health (RH) policies may be discordant. Integration may improve coverage. Medication stock-outs are a persistent problem. Quality improvement programmes are often not standard… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
18
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(20 citation statements)
references
References 51 publications
1
18
1
Order By: Relevance
“…Uganda's national policy for IPTp administration during pregnancy recommends early initiation of IPTp in the second trimester (at 13 weeks of gestation) for all women. Timely uptake of IPTp depends more on the practices of health workers at the health units coupled with quality improvement geared at improving services with accompanying strong leadership than individual characteristics of pregnant women [23]. The lower than expected uptake of IPT in our study could reflect suboptimal care at the antenatal clinics, possible stock out of drugs in the health units, and inadequate sensitization of health workers about the new guidelines on IPTp administration to pregnant women.…”
Section: Plos Onementioning
confidence: 68%
“…Uganda's national policy for IPTp administration during pregnancy recommends early initiation of IPTp in the second trimester (at 13 weeks of gestation) for all women. Timely uptake of IPTp depends more on the practices of health workers at the health units coupled with quality improvement geared at improving services with accompanying strong leadership than individual characteristics of pregnant women [23]. The lower than expected uptake of IPT in our study could reflect suboptimal care at the antenatal clinics, possible stock out of drugs in the health units, and inadequate sensitization of health workers about the new guidelines on IPTp administration to pregnant women.…”
Section: Plos Onementioning
confidence: 68%
“…Providers need to be encouraged and monitored to deliver the medicine to women consistently to increase uptake. Quality improvement processes such as supportive supervision has been prescribed to improve IPTp coverage [24,29].…”
Section: Implications For Obstetric Care and Policymentioning
confidence: 99%
“…In 2014/2015, it slightly increased to 28% [21] but then reduced to 17% in 2016 [22]. This is comparable to majority of the SSA countries whose coverage of optimal doses of IPTp-SP remains dismal according to a synthesis of results from the most recent country malaria indicator, demographic health and multiple indicator cluster surveys [23]. The results from this synthesis also showed that only Ghana, Zambia, Malawi, Sierra Leonne and Guinea had coverage of optimal doses of IPTp-SP of at least 30% [23].…”
mentioning
confidence: 94%